Lv1
4 积分 2024-11-12 加入
The use of Artificial Intelligence algorithms in drug development and clinical trials: A scoping review
2天前
已完结
Artificial intelligence
2天前
已完结
Hallmarks of artificial intelligence contributions to precision oncology
2天前
已完结
Artificial Intelligence to predict cancer risk, are we there yet? a comprehensive review across cancer types
2天前
已关闭
Artificial intelligence in liver cancer — new tools for research and patient management
2天前
已完结
Benchmark evaluation of DeepSeek large language models in clinical decision-making
3天前
已完结
The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Study
7天前
已关闭
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
8天前
已完结
LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
8天前
已完结
皖公网安备34019202002308
